CAS: 1060805-13-1 - 6-Bromo-4-methoxy-2-pyridinecarboxylic acid
Formula:C7H6BrNO3
InChI:InChI=1S/C7H6BrNO3/c1-12-4-2-5(7(10)11)9-6(8)3-4/h2-3H,1H3,(H,10,11)
InChI key:InChIKey=UCVPDRVYDNGOIX-UHFFFAOYSA-N
SMILES:O=C(O)C1=NC(Br)=CC(OC)=C1
- Synonyms:
- 6-Bromo-4-methoxy-2-pyridinecarboxylic acid
- 6-Bromo-4-methoxypyridine-2-carboxylic acid
- 2-Pyridinecarboxylic acid, 6-bromo-4-methoxy-
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 6-bromo-4-methoxypyridine-2-carboxylic acid REF: IN-DA00HAR5CAS: 1060805-13-1 | 95% | To inquire | Fri 07 Feb 25 |
 | 6-Bromo-4-methoxypicolinic acid REF: 54-OR83056CAS: 1060805-13-1 | 95% | 111.00 €~2,859.00 € | Mon 10 Feb 25 |
 | 6-Bromo-4-methoxypicolinic acid REF: 10-F454735CAS: 1060805-13-1 | 95.0% | 28.00 €~1,664.00 € | Mon 10 Feb 25 |
 | 6-Bromo-4-methoxypicolinic acid REF: 3D-FB167147CAS: 1060805-13-1 | Min. 95% | - - - | Discontinued product |
6-bromo-4-methoxypyridine-2-carboxylic acid
CAS:1060805-13-1
Formula:
C7H6BrNO3
Purity:
95%
Color and Shape:
Solid
Molecular weight:
232.0314
Ref: IN-DA00HAR5
| 1g | 172.00 € | ||
| 5g | To inquire | ||
| 100mg | 58.00 € | ||
| 250mg | 85.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
Ref: 54-OR83056
| 1g | 380.00 € | ||
| 5g | 1,633.00 € | ||
| 10g | 2,859.00 € | ||
| 250mg | 111.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
Ref: 10-F454735
| 1g | 202.00 € | ||
| 5g | 891.00 € | ||
| 10g | 1,664.00 € | ||
| 100mg | 28.00 € | ||
| 250mg | 58.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
6-Bromo-4-methoxypicolinic acid
CAS:1060805-13-1
Please enquire for more information about 6-Bromo-4-methoxypicolinic acid including the price, delivery time and more …
Formula:
C7H6BrNO3
Purity:
Min. 95%
Molecular weight:
232.03 g/mol
Ref: 3D-FB167147
| 1g | Discontinued | Request information | |
| 2g | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
